Holen Sie sich die Stockscreener-App
0.00
100.00%
-0.03
Iterum Therapeutics Plc Aktie (ITRM) Neueste Nachrichten
Iterum Therapeutics plc (ITRMF) Competitors - Meyka
Why Is Iterum Therapeutics plc (ITRMF) Stock Down Today? - Meyka
Why Is Iterum Therapeutics plc (ITRMF) Stock Up Today? - Meyka
What's going on with Iterum Therapeutics stock Monday? - MSN
Retail Surge: Does Iterum Therapeutics plc outperform in volatile markets2026 Momentum & Comprehensive Market Scan Reports - baoquankhu1.vn
Dividend HistoryIterum Therapeutics (ITRMF) - Zacks Investment Research
Published on: 2026-04-10 21:42:25 - baoquankhu1.vn
Breakout Zone: What are the future prospects of Iterum Therapeutics plc2026 Macro Impact & Weekly Market Pulse Updates - baoquankhu1.vn
ITRMF (Iterum Therapeutics) Dividend Payout Ratio : 0.00 (As of Sep. 2025) - GuruFocus
Iterum Therapeutics plc (ITRMF) stock price, news, quote and history - Yahoo Finance Australia
Iterum Therapeutics plc (ITRMF) Dividend News Alerts - DividendInvestor.com
Iterum Therapeutics plc (ITRMF) insider ownership and holdings - Yahoo Finance Singapore
ITRMF (Iterum Therapeutics) Marketable Securities : $0.00 Mil (As of Sep. 2025) - GuruFocus
EBITDA of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Cost of goods sold of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Operating expenses (excl. COGS) of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Gross profit of Iterum Therapeutics plc – OTC:ITRMF - TradingView — Track All Markets
Pretax income of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Total revenue of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Non-controlling/minority interest of Iterum Therapeutics plc – OTC:ITRMF - TradingView — Track All Markets
Diluted earnings per share (diluted EPS) of Iterum Therapeutics plc – OTC:ITRMF - TradingView — Track All Markets
EBIT of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Dilution adjustment of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Non-operating income (total) of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Operating income of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Discontinued operations of Iterum Therapeutics plc – OTC:ITRMF - TradingView — Track All Markets
Taxes of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Diluted net income available to common stockholders of Iterum Therapeutics plc – OTC:ITRMF - TradingView — Track All Markets
ITRM Iterum Therapeutics plc NASDAQ Q4 2025 results 03 Apr 2026: Earnings drivers and outlook - Meyka
Cash from investing activities of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Cash from operating activities of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Free cash flow of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Iterum Therapeutics plc Cash Flow – OTC:ITRMF - TradingView
Iterum Therapeutics plc Earnings and Revenue – OTC:ITRMF - TradingView
Iterum Therapeutics (ITRMF) Dividend Yield (TTM) - Zacks Investment Research
ITERUM THERAPEUTICS WACC %: 8.11% — 17% Below Median - GuruFocus
Total liabilities of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Total liabilities & shareholders' equities of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Net debt of Iterum Therapeutics plc – OTC:ITRMF - TradingView — Track All Markets
Iterum Therapeutics PLC (ITRMF) Stock Price & 30 Year Financial Data - GuruFocus
Iterum Therapeutics plc Balance Sheet – OTC:ITRMF - TradingView — Track All Markets
Iterum Therapeutics PLC (ITRMF) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Iterum Therapeutics PLC (ITRMF)Valuation Measures & Financial Statistics - GuruFocus
EBITDA per share of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Enterprise value to EBITDA ratio of Iterum Therapeutics plc – OTC:ITRMF - TradingView — Track All Markets
Operating cash flow per share of Iterum Therapeutics plc – OTC:ITRMF - TradingView
EBIT per share of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Working capital per share of Iterum Therapeutics plc – OTC:ITRMF - TradingView
EBITDA margin % of Iterum Therapeutics plc – OTC:ITRMF - TradingView — Track All Markets
Long term debt to total equity ratio of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Free cash flow per share of Iterum Therapeutics plc – OTC:ITRMF - TradingView
ITRMF (Iterum Therapeutics) EV-to-FCF : -1.25 (As of Apr. 03, 2026) - GuruFocus
Asset turnover of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Current ratio of Iterum Therapeutics plc – OTC:ITRMF - TradingView — Track All Markets
Tangible book value per share of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Total common shares outstanding of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Book value per share of Iterum Therapeutics plc – OTC:ITRMF - TradingView — Track All Markets
Gross margin % of Iterum Therapeutics plc – OTC:ITRMF - TradingView — Track All Markets
Price to sales ratio of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Quick ratio of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Operating margin % of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Total assets of Iterum Therapeutics plc – OTC:ITRMF - TradingView — Track All Markets
Inventory turnover of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Return on equity % of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Enterprise value of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Return on invested capital % of Iterum Therapeutics plc – OTC:ITRMF - TradingView
CapEx per share of Iterum Therapeutics plc – OTC:ITRMF - TradingView — Track All Markets
Debt to equity ratio of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Iterum Therapeutics plc Statistics – OTC:ITRMF - TradingView
Price to cash flow ratio of Iterum Therapeutics plc – OTC:ITRMF - TradingView — Track All Markets
Net margin % of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Debt to assets ratio of Iterum Therapeutics plc – OTC:ITRMF - TradingView — Track All Markets
ITRMF (Iterum Therapeutics) Gross Margin % : 94.87% (As of Sep. 2025) - GuruFocus
Net current asset value per share of Iterum Therapeutics plc – OTC:ITRMF - TradingView
2.53%
2.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):